Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimized Treatment and Regression of HBV-induced Liver Fibrosis
NCT01938781Phase 4Completed
- Sponsor
- Beijing Friendship Hospital
- Start
- Jun 2013
- Primary completion
- Dec 2016
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2a in Liver Fibrosis (LF), Chronic Hepatitis B (CHB), sponsored by Beijing Friendship Hospital. Started Jun 2013; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
Liver Fibrosis (LF)Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01938781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01938781.